ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
AbbVie Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$282.68−2.74 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $500.63B
- P/E (TTM)
- 79.9
- Dividend yield
- 2.35%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$6.65
+5.7% on the prior year
Consecutive increases
11 years
Every year since FY2014
Dividend yield
2.35%
Latest annual dividend ÷ share price
Payout ratio, FY2025
275.8%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $6.65 | +5.7% | $11.66B | 275.8% |
| FY2024 | $6.29 | +5.0% | $11.03B | 257.7% |
| FY2023 | $5.99 | +4.9% | $10.54B | 216.7% |
| FY2022 | $5.71 | +7.5% | $10.04B | 84.9% |
| FY2021 | $5.31 | +9.7% | $9.26B | 80.2% |
| FY2020 | $4.84 | +10.3% | $7.72B | 167.2% |
| FY2019 | $4.39 | +11.1% | $6.37B | 80.8% |
| FY2018 | $3.95 | +50.2% | $5.58B | 98.1% |
| FY2017 | $2.63 | +11.9% | $4.11B | 77.4% |
| FY2016 | $2.35 | +11.9% | $3.72B | 62.4% |
| FY2015 | $2.10 | +20.0% | $3.29B | 64.0% |
| FY2014 | $1.75 | -12.5% | $2.66B | 150.0% |
| FY2013 | $2.00 | – | $2.56B | – |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.